Launched in 2010, Oncotarget is a twice-weekly, traditional, peer-reviewed, multidisciplinary journal with open-access, covering research on all aspects of oncology and publishing subsections on topics beyond oncology, including gerotarget/aging, pathology (beyond oncology), immunology and microbiology, autophagy and cell death, chromosomes, and more.
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research as well as topics beyond traditional gerontology, including, but not limited to, cellular and molecular biology (e.g., regulation of translation, cell growth, death and autophagy, mitochondria, DNA damage and repair, microRNAs, stem cells), human age-related diseases, pathology in model organisms, cancer, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR among others), and approaches to modulating these signaling pathways.
Launched in 2014, Oncoscience covers the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. Oncoscience also has a special mission: freeing researchers in oncology from publication costs. It is free for the readers and the authors.
Formerly a SAGE publication, Genes & Cancer was acquired in 2014 and covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, including their roles in signal transduction and the mechanisms by which their expression and function are altered during tumor development. The Journal also invites papers in the areas of genomics, drug development and systems biology.